Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAUTEM: Preop Chemoradiotherapy + TEM vs TME in Rectal Cancer
NCT01308190Phase 3Completed
- Sponsor
- Hospital Universitari Parc Taulí
- Start
- Aug 2010
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in rectal cancer, sponsored by Hospital Universitari Parc Taulí. Started Aug 2010; status: completed.
02
Drugs
capecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01308190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308190.